J Cancer 2023; 14(14):2596-2607. doi:10.7150/jca.87196 This issue Cite
Research Paper
1. Department of Urology, Shengjing Hospital of China Medical University, Shenyang 110004, China.
2. Department of Anesthesiology, Shengjing Hospital of China Medical University, Shenyang 110004, China.
# These authors contributed equally to this work.
Cancer is a major health hazard for humans. Recent studies have indicated the involvement of small nucleolar RNAs (snoRNAs) in the occurrence and development of cancer and indicated its potential role as a diagnostic/prognostic marker and therapeutic target. The purpose of this study was to use the bibliometrics method to analyze the published literature on this subject. We collected articles pertaining to the field of snoRNA and cancer from the Web of Science Core Collection database. The data were analyzed to identify the research hotspots and frontiers. The number of articles in this field was low in the early period. Chu Liang and Montanaro Lorenzo were the most prolific authors on this subject, while Jiang and Feng were the most frequently cited authors. In China, three institutions published the most articles, namely Wuhan Univ, China Med Univ, and Guangxi Med Univ. The journal with the highest number of articles on this subject was Oncotarget. The country with the most published articles was China. Analysis of keywords and burst words indicated that early studies mainly focused on molecular mechanisms. Available evidence suggests the involvement of snoRNAs in the molecular mechanism of cancer development and their potential role as a diagnostic and prognostic biomarker.
Keywords: Bibliometric study, Small nucleolar RNA, Cancer, Molecular mechanism, Diagnosis, Prognosis